LeMaitre Vascular, Inc. – NASDAQ:LMAT
LeMaitre Vascular stock price today
$95.33
+2.48
+2.68%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 13 hours
LeMaitre Vascular stock price monthly change
+7.89%
month
LeMaitre Vascular stock price quarterly change
+7.89%
quarter
LeMaitre Vascular stock price yearly change
+60.98%
year
LeMaitre Vascular key metrics
Market Cap | 2.05B |
Enterprise value | 2.08B |
P/E | 50.50 |
EV/Sales | 9.78 |
EV/EBITDA | 34.54 |
Price/Sales | 9.79 |
Price/Book | 6.30 |
PEG ratio | 2.22 |
EPS | 1.52 |
Revenue | 199.88M |
EBITDA | 45.84M |
Income | 33.95M |
Revenue Q/Q | 13.60% |
Revenue Y/Y | 18.16% |
Profit margin | 19.4% |
Oper. margin | 23.26% |
Gross margin | 66.95% |
EBIT margin | 23.26% |
EBITDA margin | 22.94% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLeMaitre Vascular stock price history
LeMaitre Vascular stock forecast
LeMaitre Vascular financial statements
Average Price Target
$98
Potential upside: 2.80%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 50.11M | 8.09M | 16.16% |
|---|---|---|---|
| Sep 2023 | 47.41M | 7.50M | 15.82% |
| Dec 2023 | 48.88M | 8.46M | 17.32% |
| Mar 2024 | 53.47M | 9.88M | 18.49% |
0.68%
Yield TTM
| Payout ratio | 33.63% |
|---|
| 2019 | 0.95% |
|---|---|
| 2020 | 0.94% |
| 2021 | 0.88% |
| 2022 | 1.09% |
| 2023 | 0.99% |
| Jun 2023 | 326467000 | 42.64M | 13.06% |
|---|---|---|---|
| Sep 2023 | 334012000 | 45.37M | 13.58% |
| Dec 2023 | 346778000 | 48.87M | 14.09% |
| Mar 2024 | 353957000 | 45.45M | 12.84% |
| Jun 2023 | 11.90M | -9.63M | 502K |
|---|---|---|---|
| Sep 2023 | 11.82M | -9.85M | -3.12M |
| Dec 2023 | 10.74M | -2.26M | -2.68M |
| Mar 2024 | 5.07M | -2.36M | 39K |
LeMaitre Vascular alternative data
| Aug 2023 | 591 |
|---|---|
| Sep 2023 | 591 |
| Oct 2023 | 591 |
| Nov 2023 | 591 |
| Dec 2023 | 591 |
| Jan 2024 | 591 |
| Feb 2024 | 591 |
| Mar 2024 | 614 |
| Apr 2024 | 614 |
| May 2024 | 614 |
| Jun 2024 | 614 |
| Jul 2024 | 614 |
LeMaitre Vascular other data
80.84%
-6.44%
of LMAT is owned by hedge funds
170
-7
17.88M
-1.40M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2023 | 0 | 73283 |
| Feb 2024 | 0 | 64826 |
| Mar 2024 | 0 | 90771 |
| May 2024 | 0 | 210525 |
| Nov 2024 | 0 | 5414 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | ROBERTS DAVID B director, officer.. | Common Stock | 17 | N/A | N/A | ||
Option | ROBERTS DAVID B director, officer.. | Dividend Equivalent Rights | 17 | N/A | N/A | ||
Option | LEMAITRE GEORGE W director, officer.. | Common Stock | 53 | N/A | N/A | ||
Option | LEMAITRE GEORGE W director, officer.. | Dividend Equivalent Rights | 53 | N/A | N/A | ||
Option | PELLEGRINO JOSEPH P JR director, officer.. | Dividend Equivalent Rights | 17 | N/A | N/A | ||
Option | KAMKE TRENT G officer: Senior V.. | Common Stock | 9 | N/A | N/A | ||
Option | PELLEGRINO JOSEPH P JR director, officer.. | Common Stock | 17 | N/A | N/A | ||
Option | KAMKE TRENT G officer: Senior V.. | Dividend Equivalent Rights | 9 | N/A | N/A | ||
Option | JASINSKI LAWRENCE J director | Common Stock | 3 | N/A | N/A | ||
Option | JASINSKI LAWRENCE J director | Common Stock | 3 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 27 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 1 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 1 Aug 2023 | Q2 2023 Earnings Call Transcript |
LeMaitre: Further Upsides Supported By Longer Competitive Advantage Period
LeMaitre: Record Quarter, ASPs And Volumes Ratcheting Higher Equals Qualified Growth Outlook
LeMaitre: Remaining Constructive On Long-Term Valuations
LeMaitre: Balance Sheet Ready To Unlock Risk Capital, Reaffirm Buy
LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
LeMaitre Vascular: 16% Return Objective From Idiosyncratic Risk Premia
LeMaitre Vascular: Steady As She Goes
Quality GARP: 5 Stocks Screened For Value
Red Hot Inflation: Healthcare Stocks You Can Buy
-
What's the price of LeMaitre Vascular stock today?
One share of LeMaitre Vascular stock can currently be purchased for approximately $95.33.
-
When is LeMaitre Vascular's next earnings date?
Unfortunately, LeMaitre Vascular's (LMAT) next earnings date is currently unknown.
-
Does LeMaitre Vascular pay dividends?
Yes, LeMaitre Vascular pays dividends and its trailing 12-month yield is 0.69% with 34% payout ratio. The last LeMaitre Vascular stock dividend of $0.11 was paid on 2 Dec 2021.
-
How much money does LeMaitre Vascular make?
LeMaitre Vascular has a market capitalization of 2.05B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 19.69% to 193.48M US dollars.
-
What is LeMaitre Vascular's stock symbol?
LeMaitre Vascular, Inc. is traded on the NASDAQ under the ticker symbol "LMAT".
-
What is LeMaitre Vascular's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of LeMaitre Vascular?
Shares of LeMaitre Vascular can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are LeMaitre Vascular's key executives?
LeMaitre Vascular's management team includes the following people:
- Mr. George W. LeMaitre Chairman & Chief Executive Officer(age: 60, pay: $661,510)
- Mr. David B. Roberts Pres & Director(age: 61, pay: $456,580)
- Mr. Joseph P. Pellegrino Jr. Chief Financial Officer, Treasurer, Sec. & Director(age: 60, pay: $400,420)
- Mr. Trent G. Kamke Senior Vice President of Operations(age: 54, pay: $322,130)
-
How many employees does LeMaitre Vascular have?
As Jul 2024, LeMaitre Vascular employs 614 workers.
-
When LeMaitre Vascular went public?
LeMaitre Vascular, Inc. is publicly traded company for more then 18 years since IPO on 19 Oct 2006.
-
What is LeMaitre Vascular's official website?
The official website for LeMaitre Vascular is lemaitre.com.
-
Where are LeMaitre Vascular's headquarters?
LeMaitre Vascular is headquartered at 63 Second Avenue, Burlington, MA.
-
How can i contact LeMaitre Vascular?
LeMaitre Vascular's mailing address is 63 Second Avenue, Burlington, MA and company can be reached via phone at +7 812212266.
-
What is LeMaitre Vascular stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for LeMaitre Vascular in the last 12 months, the avarage price target is $98. The average price target represents a 2.80% change from the last price of $95.33.
LeMaitre Vascular company profile:
LeMaitre Vascular, Inc.
lemaitre.comExchange:
NASDAQ
Full time employees:
614
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
63 Second Avenue
Burlington, MA 01803
Burlington, MA 01803
CIK: 0001158895
ISIN: US5255582018
CUSIP: 525558201
